Journal of gastrointestinal cancerHumansFemaleGallbladder NeoplasmsGemcitabineMale
Clinical Efficacy and Safety of Gemcitabine-Cisplatin Combination in Metastatic Gallbladder Cancer: A Prospective Study from North India.
Abhinav Dewan, Vineet Talwar, Varun Goel, Sabeena K Choudhary, Krati Mehrotra, Swati Chugh, Sekhar Saha, Dharmishta Ashis Basu, Anindya Mukherjee, Rashmi Bansal, Arpit Jain, Shivashankara Swamy Mathighatta Shivarudraiah, Mansi Sharma, Pankaj Goel, Rajat Saha
Published: 202510.1007/s12029-025-01338-1
Abstract
BACKGROUND: Gemcitabine-cisplatin doublet is a standard first-line regimen for metastatic gallbladder cancer (GBC), though prospective real-world data remains scarce. We evaluated the efficacy, safety, and prognostic factors in the North Indian patie…
Preview only. Read the full abstract at the source